Boston Scientific Corporation (NYSE:BSX) Stock Has Consensus Target Price of $68.23 According to Brokerages
Boston Scientific Corporation (NYSE:BSX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the thirty-one analysts that are currently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, three have given a Boston Scientific Corporation (NYSE:BSX) has been given a consensus rating of "Moderate Buy" by 31 analysts, according to MarketBeat Ratings. The average 12-month price target among analysts is $68.23. The company has been the subject of several recent research reports. Canaccord Genuity Group reduced its target price on shares of Boston Scientific from $70.00 to $66.00 and set a "buy" rating for the company in a research report on July 30th. Barclays upgraded Boston Scientific to a "hold" rating in a report on October 7th. CEO Michael F. Mahoney recently purchased 186,240 shares of the business's stock in a transaction worth $9,000,979.20.
Published : 2 hours ago by MarketBeat in Business Finance
Boston Scientific Corporation (NYSE:BSX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the thirty-one analysts that are currently covering the stock, MarketBeat Ratings... [6454 symbols]
Topics: Markets, Stocks
